Abstract
Introduction
Sugarcane workers are exposed to potentially hazardous agrochemicals, including pesticides, heavy metals, and silica. Such occupational exposures present health risks and have been implicated in a high rate of kidney disease seen in these workers.
Methods
To investigate potential biomarkers and mechanisms that could explain chronic kidney disease (CKD) among this worker population, paired urine samples were collected from sugarcane cutters at the beginning and end of a harvest season in Guatemala. Workers were then separated into 2 groups, namely those with or without kidney function decline (KFD) across the harvest season. Urine samples from these 2 groups underwent elemental analysis and untargeted metabolomics.
Results
Urine profiles demonstrated increases in silicon, certain pesticides, and phosphorus levels in all workers, whereas heavy metals remained low. The KFD group had a reduction in estimated glomerular filtration rate (eGFR) across the harvest season; however, kidney injury marker 1 did not significantly change. Cross-harvest metabolomic analysis found trends of fatty acid accumulation, perturbed amino acid metabolism, presence of pesticides, and other known signs of impaired kidney function.
Conclusion
Silica and certain pesticides were significantly elevated in the urine of sugarcane workers with or without KFD. Future work should determine whether long-term occupational exposure to silica and pesticides across multiple seasons contributes to CKD in these workers. Overall, these results confirmed that multiple exposures are occurring in sugarcane workers and may provide insight into early warning signs of kidney injury and may help explain the increased incidence of CKD among agricultural workers.
Keywords: chronic kidney disease of an unknown etiology, climate, energy metabolism, exposome, metals, pesticides
Graphical abstract
See Commentary on Page 1163
Sugarcane is the most cultivated crop in the world, with nearly 2 billion tons produced every year. It has a variety of extremely valuable applications, ranging from its ubiquitous presence in food and increasing role in ethanol production to the use of sugarcane stalk pulp (bagasse) in energy production. Therefore, it comes as no surprise that production has continued to trend upward over recent decades.1 Sugarcane field work involves a number of distinct job tasks, all of which demonstrate some degree of occupational risk and increased prevalence of renal injury, especially in cane cutters when preventive strategies are uncertain or not fully implemented. Cane cutters work an extremely physically demanding job for long hours in hot weather with limited rest breaks, shade, and opportunities for rehydration; they often work directly with recently burned sugarcane without respiratory protection and are exposed to high volumes of respirable ash.2, 3, 4 Heat stress, exertional injury, dehydration, and exposure to agricultural toxicants are major occupational concerns that are posited as being responsible for the growing incidence of CKD among these communities.5
In addition to increasing rates of CKD globally and in agricultural communities, an epidemic of CKD of unknown etiology (CKDu), also referred to as Mesoamerican nephropathy, has been posited to be the consequence of performing high exertion work in the face of increasing heat plus exposure to nephrotoxicants.6, 7, 8, 9 Agricultural communities in particular experience disproportionate CKDu rates, with hot spots in Latin America, India, and Sri Lanka, among other mostly subtropical countries.10,11 Clinically, CKDu is defined as CKD that is not a comorbidity of diabetes, hypertension, kidney stones, or other known causes of kidney disease. It has a gradual onset characterized by a decline in kidney function as measured by serum creatinine or serum cystatin C with low or no proteinuria. Histopathologically, CKDu is characterized by tubulointerstitial nephritis and fibrosis, with glomerulosclerosis appearing in later stages of illness.12,13 Unfortunately, the mechanistic understanding of CKDu remains extremely limited, impeding the development of effective treatments or diagnostic techniques. Given that CKDu and the rise in kidney injury are likely linked, investigating common exposures in these areas will help elucidate the primary risk factors responsible for the rapid degradation of renal health. Public health interventions addressing strenuous working conditions, heat stress, and dehydration have found some success in acute kidney injury mitigation, but such factors are unable to fully explain CKDu distribution and prevalence.14, 15, 16, 17 Thus, there remains a strong possibility that one or more environmental toxicants is contributing to the development of this disease via other mechanisms of kidney injury.
Sugarcane agricultural work involves the use of many pesticides, fertilizers, and heavy metals, which could result in exposure to these nephrotoxic chemicals.18 Although pesticides and heavy metals have a well-documented risk of kidney damage, investigations into their role in the development of CKDu are ongoing. Current literature has yet to demonstrate a conclusive link, with many studies providing contradictory results and meta-analyses not finding any statistically significant risks.19, 20, 21, 22, 23, 24 A more recent hypothesis centers on a putative role for silica nanoparticles. Sugarcane stalks are comprised primarily of naturally occurring amorphous silica, which can be released during routine crop burning.4 Evidence of such exposures have been found in the biopsies of some CKDu patients.25 In addition, these particles have been found to be cytotoxic and disruptive of energy metabolism in human kidney cells.26
Understanding the mechanism of energy metabolism perturbation that occurs following exposure to nephrotoxicants could elucidate the exposures and stressors that contribute to pathogenesis. Kidney disease is known to be associated with inflammatory renal tubular injury, altered redox state, fibrosis, and mitochondrial dysfunction.27,28 Altered redox state, glycolytic shift, and accumulation of fatty acids are hallmarks of CKD that have also been demonstrated to occur in vitro following exposure to amorphous silica nanoparticles.26,29,30 Such processes and pathways have many associated metabolites that can be quantified via metabolomics to help understand exposures and risk factors correlated with higher rates of kidney injury. In addition, elemental and pesticide analysis provides a snapshot of the exposome of high-risk groups during key periods, clarifying associations between occupational and environmental exposures and biological indicators of kidney injury.
The hypothesis of this study was that the exposome and metabolome changes that occur concurrently in sugarcane cutters over the harvest season can provide a multifactorial snapshot of early kidney injury, which can be used to better understand potential mechanisms and biomarkers of CKDu. To this end, paired urine samples were collected from cutters at 2 timepoints across the 6-month harvest season. Cross-harvest changes to elemental abundance, presence of pesticides, and metabolic profiles were investigated to determine trends which may correlate with markers of kidney function.
Methods
Study Design
The data for this analysis were derived from stored urine samples from a previous study of male agricultural workers (≥18 years) employed by a sugarcane agribusiness in Guatemala. The study was conducted during the 2017 to 2018 harvest among 202 sugarcane cutters. The harvest season lasted 6 months from November through May. For the original study, participants were recruited within 2 randomly selected work groups of male sugarcane cutters in November 2017. Clinical data and urine and blood samples were collected during November 2017 and April 2018 before the start of the work shift. These workers live in the Guatemala highlands during the rainy season and migrate to the lowlands for seasonal work where they are housed in dormitories on company property where they predominately consume the same water and prepared meals. During the harvest season, agrochemicals were applied, and the sugarcane fields were burned to facilitate harvest as a standard practice in this region. Additional work setting, worker population, work practice, and study method details have been previously described.31,32 Participants provided written informed consent at the time of recruitment, and institutional review board approval for this study was obtained from the Colorado Multiple Institutional Review Board of the University of Colorado and Comité de Ética Independiente ZUGUEME in Guatemala.
For this current analysis, untargeted metabolomics and elemental analysis were performed on a paired group of urine samples from 20 workers collected in November and April to determine cross-harvest changes, totaling 40 urine samples. To minimize diurnal variation, worker urine samples were excluded from selection if collection time during the day differed between November and April (Figure 1). Out of the original population of 202, 80 workers had morning urine samples collected in both November and April. Among these 80 workers, 38 had a decline in eGFR from November to April, 19 of whom experienced a decline greater than or equal to 9% and were randomly selected from to comprise the KFD group. For 42 of the 80 workers, their eGFR maintained or increased and had a value greater than 90 at both timepoints, 16 of whom maintained kidney function (0%–5% increased eGFR) and were randomly selected from to comprise the group with no decline in kidney function (non-KFD). The eGFR was calculated from serum creatinine values using established methods.33 Urine creatinine, kidney injury marker 1, and electrolyte values were determined via previously discussed methods.32
Figure 1.
Study population selection.
Sample Collection and Storage
Urine samples were morning spot samples collected at approximately the same time in November and April before workers began their shift. Specific gravity was determined at the time of collection. Samples were placed on ice and transported to the on-site clinic within 1 hour after collection, where the urine was aliquoted into Fisherbrand sterile polypropylene tubes without preservatives before local storage at −20 ºC and laboratory analysis at Guatemala City. Within 1 week, frozen urine aliquots were shipped on dry ice to the University of Colorado Anschutz Medical Campus. Upon arrival, they were immediately stored at −80 ºC before metabolomic and elemental analysis.
Elemental Analysis
Urine samples were diluted 1:1 in 70% HNO3 and left to sit at least overnight for wet digestion. Samples were then diluted 1:100 in 1.5% HNO3 for instrumental analyses. Inductively coupled plasma-mass spectrometry analyses were performed on a NexION 2000B single quadrupole ICP-MS (Perkin-Elmer, Waltham, MA) equipped with a Meinhard nebulizer and a cyclonic spray chamber. Each day, prior to analyses, the instrument was tuned with a solution of 1 part per billion Li, Ce, In, Pb, and U to optimize sensitivity and robustness. Samples were analyzed via total quantitative analysis, scanning from m/z ratios of 7 to 238 to determine concentration of each individual element in the sample. Samples were calibrated to a 1-point external standard point of a 10-parts per billion cocktail of 40 metals. Data are presented in total parts per billion (μg/l) in urine normalized to creatinine (g/l).
Metabolomics
All solvents used for extraction and liquid chromatography-mass spectrometry analysis were of high-performance liquid chromatography or liquid chromatography-mass spectrometry grade, including water from Burdick and Jackson (Muskegon, MI) and acetonitrile, methanol, and formic acid from Fisher Scientific (Fair Lawn, NJ). Authentic standards were from Cayman Chemical (Ann Arbor, MI), Cambridge Isotope Laboratories (Tewksbury, MA), CDN Isotopes (Pointe-Claire, Quebec, Canada), and Millipore-Sigma (St. Louis, MO).
Sample Preparation
Urine samples were analyzed neat as previously described with some modifications as previously described.34 Briefly, urine samples and a pooled urine quality control (QC) sample were thawed at 4 oC, and 100 μl aliquots were stored in 1.5 ml microcentrifuge tubes overnight at 4°C until sample preparation. Samples and the pooled QC samples were centrifuged for 10 minutes at 3000g and 4°C (Beckman-Coulter). Then 35 μl of sample supernatants were transferred to autosampler vials (Cornerstone Scientific) in a 4 °C cold room. A 160 μl aliquot of the pooled QC sample, made from 4 μl aliquots of each urine sample, was transferred to a fresh 1.5 ml microcentrifuge tube (Fisher Scientific) and was spiked with 20 μl each of an in-house hydrophilic spike mix and 8-iso PGF2α (Cayman Chemical).35 The spiked pooled QC sample was vortexed well to mix and 40 μl aliquots were transferred to autosampler vials. All samples and pooled QC aliquots were stored at −80 °C until instrumental analysis.
Liquid Chromatography-Mass Spectrometry
Urine samples were analyzed by reverse-phase chromatography as previously described with the following modifications: the SB-AQ analytical column was fitted with an in-line filter frit (Agilent Technologies, Santa Clara, CA); mobile phase A was composed of water with 0.1% formic acid and 0.1% InfinityLab deactivator additive (Agilent Technologies); mobile phase B was composed of acetonitrile with 0.1% formic acid and 0.1% InfinityLab deactivator additive; the gradient was as follows: 0 to 3 minutes, 1.8% B; 3 to 10 minutes, 1.8% to 54% B; 10 to 15 minutes, 54% to 90% B; 15 to 20 minutes, hold at 90% B; 20 to 20.1 minutes, 90% to 1.8% B; hold at 1.8% B until 25 minutes.34 The Agilent Technologies 6545 Time-of-Flight Mass Spectrometer conditions were as previously described.35
QC
Pooled QC samples were injected after every 10 samples to monitor instrument variability across the run. Detected spiked-in standards had coefficient of variations of 6.5% or lower across 7 pooled QC injections.
Data Processing and Annotation
Raw liquid chromatography-mass spectrometry data were extracted using a recursive workflow in MassHunter Profinder Version B.10, SP1 (Agilent Technologies), similar to that previously described with the following modifications: retention time extraction range of 0.5 to 13 minutes with a noise peak height filter ≥7500 counts; ion species: +H, +Na, +K, +NH4; and charge state maximum of 1. Alignment tolerance for RT was 0% + 0.20 minutes with a mass tolerance of 10 ppm + 2 mDa (millidalton).34 Data were imported into Mass Profiler Professional Version 14.1 (Agilent Technologies) for quality filtering. Compounds remaining after filtering were used for targeted feature extraction in Profinder. Compounds resulting from targeted data extraction were imported into Mass Profiler Professional Version for differential analysis. Differential analysis was performed using Mass Profiler Professional Version 14.1 (Agilent Technologies), using a workflow similar to that previously described.34 Analysis of variance was performed using a P-value of <0.05. A fold change filter of 1.5 was applied to analysis of variance results.
Compound Annotation
Compounds were annotated using MassHunter ID Browser B.08 (Agilent technologies) to search in-house and publicly available or commercial databases. The in-house database is composed of a set of 683 authentic standards; database matches were based on isotope ratios, neutral mass (using a 10 ppm window), and retention time. Public and commercial databases included HMDB 4.0, Lipid Maps, Metlin and KEGG.36, 37, 38, 39 Annotations from public or commercial databases were based on accurate mass, with a mass error cutoff of 10 ppm, isotope ratios. A match score cutoff of 60 was applied.
Statistical Analysis
Demographic and biomarker data were compared between time points (November and April) and between groups (non-KFD and KFD) using the Wilcoxon-Mann Whitney test. Principal component analysis graphs and pathway enrichment or topology analysis tables were created using MetaboAnalyst 5.0 and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database or Small Molecule Pathway Database with a false discovery rate corrected P-value (q-value) threshold of 0.05 used to determine statistical significance. All other statistical analyses and graphics were performed or generated in GraphPad Prism (Version 8.4.3; La Jolla, CA) using a paired t-test with Holm-Šídák multiple comparisons correction and a P-value threshold of 0.05 to determine statistical significance.
Results
Demographics and Laboratory Features
The demographic features of both groups (non-KFD vs. KFD) reveal that the workers with evidence of KFD were, on average, older and weighed more at the start of the season (Table 1). Urine creatinine and specific gravity indicate more dilute urine at the end of the harvest season; however, kidney injury marker 1 levels were still within normal ranges at both timepoints. In April, workers with KFD had significantly higher levels of urine potassium and chloride compared to non-KFD workers.
Table 1.
Demographic and biomarkers descriptives among sugarcane cutters at the start of the harvest, November, and the end of the harvest, April, stratified by workers with normal kidney function (non-KFD) and workers with evidence of kidney function decline (KFD)
| Characteristics | Normal Kidney Function (non-KFD) (n = 10) |
Kidney Function Decline (KFD) (n = 10) |
||
|---|---|---|---|---|
| November | April | November | April | |
| Demographics | ||||
| Age, yr, mean (SD) | 24 (7) | - | 29 (3) | - |
| HbA1c, %, mean (SD) | 5.3 (0.1) | - | 5.4 (0.3) | |
| Systolic blood pressure, mm Hg, mean (SD) | 108 (14.8) | 109.6 (7.7) | 106 (8.4) | 109.6 (8) |
| Diastolic blood pressure, mm Hg, mean (SD) | 75 (7.1) | 62.9 (4.2)a | 70 (9.4) | 59.5 (9.4) |
| Height, m, mean (SD) | 1.6 (0.1) | - | 1.6 (0.1) | - |
| Weight, kg, mean (SD) | 56.5 (6.0) | 53.9 (5.5) | 62.3 (6.6) | 59.2 (8.4) |
| Markers of kidney function | ||||
| Serum creatinine, mg/dl, mean (SD) | 0.79 (0.10) | 0.77 (0.10) | 0.79 (0.14) | 1.02 (0.18)a |
| eGFR, ml/min per 1.73 m2, mean (SD) | 125.9 (8.1) | 127.3 (7.7) | 122.9 (11.6) | 103.2 (17.8)a |
| Percent change in eGFR, mean (SD), min–max | - | 1.1 (0.99), 0–3.00 | −21.00 (13.48), −53.00 to −9.00 | |
| Albumin-to-creatinine ratio, mg/g, mean (SD) | 9.3 (6.0) | 8.4 (4.5) | 6.4 (5.2) | 7.6 (2.3) |
| Urine KIM-1, pg/ml (SD) | 1014 (817.2) | 352.5 (598.3) | 649.3 (691.7) | 239.7 (196.9) |
| Urine KIM-1, pg/g creatinine | 869 (677) | 690 (1432) | 464 (514) | 299 (204) |
| Urine biomarkers | ||||
| Urine creatinine, mg/dl, mean (SD) | 135.8 (67.7) | 69.2 (35.3)a | 135.4 (67.6) | 80.5 (40.6)a |
| Urine albumin, mg/l, mean (SD) | 14.59 (16.31) | 4.67 (1.48)a | 8.19 (7.13) | 5.51 (1.79) |
| Urine lactate, mmol/l, mean (SD) | 3.09 (1.41) | 1.84 (1.06)a | 5.47 (3.24) | 2.02 (0.72)a |
| Urine phosphate, mg/dl, mean (SD) | 38.35 (27.75) | 22.48 (11.92) | 19.44 (12.66) | 29.44 (24.43) |
| Urine magnesium, md/dl, mean (SD) | 9.54 (5.59) | 7.93 (3.21) | 7.19 (3.06) | 8.17 (4.24) |
| Urine sodium, mmol/l, mean (SD) | 60.90 (33.39) | 44.6 (28.91) | 73.56(31.34) | 63.2 (41.56) |
| Urine potassium, mmol/l, mean (SD) | 60.96 (26.37) | 19.43 (12.82)a | 47.68 (16.4) | 33.38 (10.33)a |
| Urine chloride, mmol/l, mean (SD) | 139.0 (52.51) | 56.1 (27.79)a | 130.11 (39.38) | 91.2 (38.7) |
| Urine specific gravity, mean (SD) | 1.019 (0.006) | 1.010 (0.005)a | 1.018 (0.006) | 1.013 (0.004) |
| Urine pH, mean (SD) | 5.85 (0.63) | 6.45 (0.83) | 6.00 (1.00) | 6.05 (0.92) |
eGFR, estimated glomerular filtration rate; KFD, kidney function decline; KIM-1, Kidney Injury Molecule-1.
indicates a P-value <0.05 between November and April within groups using the Wilcoxon-Mann Whitney test.
Elemental Analysis
Inductively coupled plasma mass spectrometry analysis revealed consistent trends in elemental levels in urine over the harvest season. Silicon and phosphorus were found to increase significantly from November to April, with silicon levels being higher in every sample (Figure 2a) and phosphorus in 85% of samples (Figure 2b). Interestingly, the concentration of metals hypothesized to be associated with CKDu (i.e., nickel, cadmium, lead, and arsenic) remained stable over the harvest season (Figure 2c). Individual values for all samples can be found in the supplementary material (Supplementary Table S1).
Figure 2.
Inductively coupled plasma mass spectrometry (ICPMS) analysis found urinary concentrations of silicon (a) and phosphorus (b) significantly increased over the harvest season, whereas nephrotoxic metals, nickel, cadmium, lead, and arsenic (c) did not change significantly. Each dot represents an individual worker sample (n = 20). Dashed lines represent upper reference values (in μg/l) from the literature for nickel, from the Occupational Safety and Health Administration for cadmium, and from the Agency for Toxic Substances and Disease Registry (ATSDR) for arsenic.40, 41, 42 For lead, the dashed line is based on the geometric mean of nonsmokers from the ATSDR’s 2020 Toxicological Profile for lead.43 Data were analyzed with a paired t-test with Holm-Šídák multiple comparisons correction (∗indicates a P-value <0.05, ∗∗ indicates a P-value <0.01). KFD, kidney function decline.
Metabolomic Analysis
Untargeted metabolomics detected 4799 compounds, 3150 of which were present in ≥50% of samples, 3419 of which were present in ≥50% of November samples, 2963 of which were present in ≥50% of April samples, and 1154 of which were detectable in all samples (Supplementary Table S2). Metabolite data were normalized to creatinine, with the metabolites demonstrating the greatest change over the harvest season expressed in the form of an increased or decreased foldchange heat map (Figure 3a). These metabolites consisted primarily of amino acids, botanical compounds, and fatty acids. Metabolic changes were consistent among subgroups, with minimal variation between KFD and non-KFD workers. When visualized in the context of a principal component analysis plot (Figure 3b), this becomes even more evident. Despite having reduced eGFR, metabolic profiles of KFD workers demonstrated high intergroup clustering with non-KFD workers. However, there was evidence of cross-harvest changes, with samples from the start of the harvest season (November) clearly separating from samples at the end of the harvest season (April). To further explore these changes, data were uploaded to MetaboAnalyst and underwent pathway enrichment and topology analysis within the context of the Small Molecule Pathway Database (Table 2) and the KEGG database (Supplementary Table S3). There were several significantly impacted pathways, including altered amino acid metabolism, fatty acid oxidation, glutathione homeostasis, and various energetic pathways (i.e., pyruvate and carnitine metabolism). In addition, there were signs of perturbation to nicotinamide adenine dinucleotide (NAD+) biosynthesis in the form of altered tryptophan, nicotinate, and nicotinamide metabolism. Specific compound hits from pathway analysis (Table 3) followed similar trends across the harvest season, with comparable fold change values between KFD and non-KFD workers (Supplementary Figure S1).
Figure 3.
Heat map of metabolite fold change from November to April (a) reveals highest up and down regulated metabolites are primarily those associated with fatty acid and amino acid metabolism. Principle component analysis (PCA) plots (b) demonstrate high clustering based on time point among all workers (top figure) and among both kidney function decline (KFD) and non-KFD agricultural workers (bottom figure). Original compound values were log2 transformed, normalized to creatinine, and analyzed via metaboanalyst (n = 20). KFD, kidney function decline.
Table 2.
Significantly impacted pathways based on the Small Molecule Pathway Database with P-values from pathway enrichment analysis and pathway impact values from pathway topology analysis
| Pathway | Total compounds | Hits | November vs. April (All) | November (Non-KFD) vs. April (Non-KFD) | November (KFD) vs. April (KFD) | April (Non-KFD) vs. April (KFD) | Impact |
|---|---|---|---|---|---|---|---|
| Betaine Metabolism | 18 | 3 (Betaine aldehyde; Betaine;Homocysteine) | 5.0252E-07 | 0.008983 | 0.000020551 | 0.11756 | 0.34862 |
| Carnitine Synthesis | 16 | 1 (3-Hydroxy-N6,N6,N6-trimethyl-L-lysine) | 0.00084994 | 0.038378 | 0.0047409 | 0.88928 | 0.32941 |
| Histidine Metabolism | 35 | 1 (L-Histidine) | 0.014709 | 0.010182 | 0.18375 | 0.75647 | 0.23416 |
| Methionine Metabolism | 39 | 3 (Homocysteine; Sarcosine; Betaine) | 3.8911E-07 | 0.0085505 | 0.000020551 | 0.75074 | 0.14308 |
| Tryptophan Metabolism | 55 | 2 (3-Hydroxyanthranilic acid; Tetrahydrobiopterin) | 0.000058313 | 0.01131 | 0.004632 | 0.32579 | 0.071296 |
| Glycine and Serine Metabolism | 50 | 4 (Pyruvaldehyde; Homocysteine; Betaine; Sarcosine) | 1.0558E-08 | 0.00080861 | 0.000020551 | 0.011282 | 0.067324 |
| Beta-Alanine Metabolism | 26 | 2 (L-Histidine; Ureidopropionic acid) | 0.0027437 | 0.010182 | 0.078916 | 0.006329 | 0.066116 |
| Androstenedione Metabolism | 23 | 2 (Etiocholanolone glucuronide; Etiocholanolone) | 0.00036168 | 0.0085505 | 0.072899 | 0.3314 | 0.053333 |
| Pyrimidine Metabolism | 54 | 2 (Ureidopropionic acid; Ureidoisobutyric acid) | 0.00015386 | 0.010182 | 0.013997 | 0.006329 | 0.029225 |
| Pterine Biosynthesis | 18 | 1 (Tetrahydrobiopterin) | 0.0031783 | 0.029289 | 0.073112 | 0.3751 | 0.012869 |
| Nicotinate and Nicotinamide Metabolism | 32 | 1 (Nicotinamide riboside) | 0.0010067 | 0.018867 | 0.039495 | 0.34175 | 0.010436 |
| Tyrosine Metabolism | 55 | 3 (Ascorbic acid; Tetrahydrobiopterin; 5,6-Dihydroxyindole) | 0.000058119 | 0.000066355 | 0.06462 | 0.32579 | 0.0014347 |
| Ammonia Recycling | 25 | 1 (L-Histidine) | 0.014709 | 0.010182 | 0.18375 | 0.32658 | 0 |
| Catecholamine Biosynthesis | 14 | 1 (Ascorbic acid) | 0.00056843 | 0.0085505 | 0.058653 | 0.13075 | 0 |
| Homocysteine Degradation | 7 | 1 (Homocysteine) | 1.4172E-06 | 0.010182 | 0.000020551 | 0.74332 | 0 |
| Pyruvaldehyde Degradation | 7 | 1 (Pyruvaldehyde) | 3.2267E-09 | 0.000054311 | 0.00012806 | 0.8889 | 0 |
| Pyruvate Metabolism | 37 | 1 (Pyruvaldehyde) | 3.2267E-09 | 0.000054311 | 0.00012806 | 0.89075 | 0 |
| Vitamin B6 Metabolism | 15 | 1 (4-Pyridoxic acid) | 0.00064053 | 0.010587 | 0.031123 | 0.077747 | 0 |
KFD, kidney function decline.
Data is ordered by descending impact factor (q value <0.05 is indicated by a bolded value). Original compound values were log2 transformed and analyzed via metaboanalyst (N = 20).
Table 3.
Compound hits from pathway analysis with fold change from November to April and across groups with or without KFD
| Compounds | November vs. April (All) | November (Non-KFD) vs. April (Non-KFD) | November (KFD) vs. April (KFD) | April (Non-KFD) vs. April (KFD) |
|---|---|---|---|---|
| Betaine aldehyde | 1.0394004 | 1.1351618 | 0.943639 | −0.7584812 |
| 3-Hydroxy-N6, N6,N6-trimethyl-L-lysine | 1.1236717 | 1.1721541 | 1.0751893 | −0.4505893 |
| L-Histidine | 0.7307202 | 0.9475248 | 0.5139156 | −1.18501835 |
| Homocysteine | 3.42772305 | 2.8106313 | 4.0448148 | −0.0611859 |
| Sarcosine | 1.359087625 | 1.44399085 | 1.2741844 | −1.0571272 |
| Betaine | 0.6151725 | 0.55932625 | 0.67101875 | −0.07658775 |
| 3-Hydroxyanthranilic acid | 1.45654495 | 0.5908845 | 2.3222054 | −0.1527283 |
| Tetrahydrobiopterin | 0.956942125 | 1.01491395 | 0.8989703 | −0.1508771 |
| Pyruvaldehyde | 2.0163203 | 2.2148971 | 1.8177435 | −0.3794771 |
| Ureidopropionic acid | 0.670869 | 0.73045375 | 0.61128425 | −0.19337995 |
| Etiocholanolone glucuronide | −0.19546855 | −0.32636545 | −0.06457165 | −0.0285683 |
| Etiocholanolone | −0.993823325 | −1.3519187 | −0.63572795 | 0.26880215 |
| Ureidoisobutyric acid | 1.03568835 | 1.16121055 | 0.91016615 | −0.0829997 |
| Nicotinamide riboside | 1.030189025 | 1.1395568 | 0.92082125 | −0.40516915 |
| Ascorbic acid | 1.3980836 | 1.5413648 | 1.2548024 | 0.0890468 |
| 5,6−Dihydroxyindole | −0.79335603 | −1.23406921 | −0.35264285 | 0.93608066 |
| 4-Pyridoxic acid | 2.276566175 | 3.1774513 | 1.37568105 | −0.4154801 |
KFD, kidney function decline.
Original compound values were log2 transformed, normalized to creatinine, and analyzed via metaboanalyst (n = 20).
Metabolite Abundance Trends
Fatty acid accumulation is a hallmark of CKD and is indicative of impaired beta oxidation, reduced mitochondrial function, and perturbed energy metabolism. Metabolites associated with such pathways were quantified and analyzed via paired t-tests between November and April timepoints (Figure 4a). N6,N6,N6-trimethyl-L-lysine, valerylcarnitine, deoxycarnitine, dodecanedioylcarnitine, L-hexanoylcarnitine, and octanoyl-L-carnitine were found to increase significantly in abundance. Propionyl-L-carnitine abundance was found to decrease. Next, we similarly investigated amino acid metabolites known to correlate with compromised renal function, kidney injury, and disease progression (Figure 4b). Histidine, L-isoleucine, methionine, proline, valine, sarcosine, pyrimidine, and homocysteine were all found to be higher in abundance at the end of the harvest season.
Figure 4.
Trends in fatty acid (a) and amino acid (b) metabolites over the harvest season among all workers were consistent with known signs of impaired renal function and kidney disease. Data is presented as log2 signal intensity normalized to creatinine and each dot represents an individual worker sample (n = 20). Data were analyzed with a paired t-test with Holm-Šídák multiple comparisons correction (∗ indicates a P-value <0.05, ∗∗ indicates a P-value <0.01, ∗∗∗ and ∗∗∗∗ indicate a P-value <0.001 and <0.0001, respectively).
Pesticide Metabolomics
Metabolite compounds demonstrating ≥1.5-fold change over the harvest season (Supplementary Table S4) were searched against a pesticide database and expressed as a heat map (Figure 5a). Although the majority of detected pesticide metabolites were not found to increase from November to April, carbofuran-3-keto, metolachlor, diquat, and paraquat were found to increase significantly over the harvest season (Figure 5b).
Figure 5.
Heat map of pesticide metabolite trends from November to April. Overall pesticide metabolite trends remained consistent across groups (a). Workers with normal kidney function (non-KFD) demonstrated greater apparent decreases in some metabolites over the harvest season; however, metabolite abundance of certain potentially nephrotoxic pesticides increased across the season in both groups (b). Original compounds were referenced to a pesticide database, values were log2 transformed, and normalized to creatinine. Data is presented as fold change over the harvest season (n = 20). Potentially nephrotoxic pesticide metabolites were analyzed with a paired t-test with Holm-Šídák multiple comparisons correction (∗ indicates a P-value <0.05, ∗∗ indicates a P-value <0.01). KFD, kidney function decline.
Discussion
This study demonstrates the value of a combined exposome and metabolome analysis, providing insights into agricultural workers’ key occupational risk factors and potential mechanisms of CKDu pathogenesis in agricultural field workers exposed to complex climatologic and environmental exposure conditions.
Exposomic analysis of urine samples revealed elevated levels of silicon over the harvest season, indicating a consistent occupational exposure among sugarcane cutters, with potential renal health risks. Nephrotoxic metals remained low, suggesting minimal exposure. Several pesticides, including some which have been implicated as potentially nephrotoxic, were found to increase in abundance from November to April. This demonstrates evidence of pesticide uptake and may help explain the metabolome changes which were found to occur over the harvest season, including altered energy metabolism and trends in metabolite abundance consistent with CKD biomarkers. Understanding these exposures and the key risk factors at play is critical as new epidemics of kidney disease, including CKDu, continue to increase around the world.44
Exposure to heavy metals has long been known to cause renal damage and is suspected of playing a key role in recent epidemics of kidney injury, due to use of agrochemicals known to contain nephrotoxic metals and some evidence of elevated heavy metal levels in agricultural communities’ water sources.21,45, 46, 47, 48, 49 Indeed, arsenic, cadmium, and lead are pervasive toxicants with established mechanisms for inducing both acute kidney injury and CKD, resulting in ongoing investigations into potential contributions to the epidemics of CKDu occurring worldwide.50,51 Although some association of heavy metals have been made with increased risk of CKDu, such findings have been inconsistent.23,24 Thus, it is unsurprising that elemental analysis found that urinary levels of heavy metals were relatively low and did not increase significantly over the harvest.40, 41, 42, 43 It is important to emphasize that the agricultural company where these workers were employed had implemented a program to reduce worker exposure to heavy metal contaminated water through routine QC testing for metals in their supplied drinking water. We would caution against generalizing from the observation of low heavy metal exposure because the exposure control efforts of this company may not be representative of the industry at large and urine samples are less accurate than blood tests for determining chronic exposure to certain metals.
Unlike heavy metals, urinary abundance of silicon increased over the harvest season. This confirms that silicon is a concerning occupational exposure and lends additional support to evidence of cane worker exposure and absorption of silica nanoparticles via ash inhalation from sugarcane burning and/or groundwater consumption.52 Such amorphous silica carries known risks and can be resistant to clearance, potentially leading to accumulation after each harvest.53, 54, 55, 56, 57, 58 This accumulation in the kidney tissue, as has been demonstrated in worker biopsies, may limit urinary excretion and could explain why abundance did not differ significantly between KFD and non-KFD groups.59 Elevated phosphorus is also notable as a known indicator of renal damage resulting in altered kidney function. Renal proximal tubular cells are responsible for maintaining phosphate homeostasis through reabsorption; exposure to nephrotoxic metals, pesticides, and/or silica could damage these cells and result in increased urinary phosphate excretion.60,61 However, such damage would generally be expected to be accompanied by increased kidney injury marker 1 levels, rather than the slight cross-harvest decrease observed. High phosphate has been found to be associated with reactive oxygen species generation, mitochondrial dysfunction, cell death, and progression of CKD.62, 63, 64, 65, 66 Interestingly, similar hallmarks of kidney disease have been found in vitro following silica nanoparticle exposure and in animal models following sugarcane ash exposure.26,57,58 As with silicon, phosphorus abundance was comparable between KFD and non-KFD workers despite increasing over the harvest season. One reason for this could be that reduced glomerular filtration rate can limit renal clearance, causing levels to appear lower than expected, particularly when normalizing elemental expression to creatinine.
Pesticides are another occupational and community exposure of concern, due in part to their abundant use in agricultural communities and tendency to contain nephrotoxic components. Previous epidemiologic investigations into the link between pesticide exposure and CKDu have produced varying results, with several finding positive associations.20,21,67, 68, 69 Carbofuran, metolachlor, paraquat, and diquat are 4 of such compounds which are known to cause acute kidney injury and have been previously implicated in CKD.67,69, 70, 71, 72, 73, 74 In particular, a recent study found evidence that paraquat might have a participatory role in CKDu from Central America.75 These pesticides and associated metabolites were found to increase in abundance over the harvest season, across both KFD and non-KFD workers. Even if such exposures are not solely responsible for elevated rates of kidney disease seen among this population, they are yet another nephrological stressor that could be contributing to pathogenesis. CKDu etiology is likely multifactorial. We speculate that even low levels of pesticide exposure could be hazardous if occurring alongside chronic exposure to silica, heavy metals, heat stress, and dehydration. Characterizing the metabolomic state of individuals who experience multiple exposures is essential to determine specific mechanisms and pathways involved in pathogenesis.
Alteration in energy metabolism is a hallmark of CKD, which has been found to occur in populations at high risk for CKDu.28 The kidney is an extremely energy-intensive organ, requiring large amounts of functional mitochondria to remain healthy.76 It is therefore highly sensitive to any changes in energy production, with disease states demonstrating pronounced shifts in energy metabolism. Nicotinamide metabolism was altered significantly over the harvest season, along with carnitine synthesis, pyruvate metabolism, and expression of several fatty acid metabolites. NAD+ is a crucial coenzyme for a variety of cellular processes, including DNA repair, cellular senescence, and energy metabolism.77 Perturbed energy metabolism associated with NAD+ is known to occur in states of kidney stress, with depletion leading to ischemia and renal tubular injury.78, 79, 80 Increased abundance of free fatty acids is indicative of inhibited beta oxidation of fatty acids, a key mechanism of ATP generation in the kidney.29,81, 82, 83, 84, 85 This trend is not only linked with CKD, but specific fatty acid metabolites were found to follow the same pattern as occurred in vitro following exposure to silica nanoparticles derived from sugarcane ash.26 Furthermore, the only fatty acid associated metabolite that was found to undergo a significant decrease both over the harvest season and in vitro was propionyl-l-carnitine, a metabolite which has known nephroprotective effects.86,87 Beyond nicotinamide and lipid metabolism perturbation, a variety of amino acid metabolites (i.e., histidine, methionine, or valine) were found to demonstrate signs consistent with impaired renal function and kidney disease.88, 89, 90, 91, 92, 93, 94, 95 Phenylacetic acid and acetaminophen glucuronide were other metabolites of concern found to increase in abundance over the harvest season, the former of which has been found to be elevated in CKD patient and both of which are capable of inducing inflammation and oxidative stress.96, 97, 98, 99, 100 These changes are consistent with inhibition of mitochondrial respiration, perturbed lipid metabolism, and glycolytic shifts that occur during ischemic acute kidney injury. If injury is so severe that cells are unable to recover from the stress and energy production remains insufficient, this can be followed by proximal tubule atrophy, fibrosis, and a transition to CKD.101 It is this pathology that is seen both in CKDu patient biopsies as well as in vivo models of silica exposure.
There are several limitations which must be acknowledged and considered to contextualize these findings. The sample size and timepoints of this study are key considerations. Although many elemental and metabolic trends were consistent throughout groups and over the harvest season, it is unclear whether such findings would remain consistent over multiple harvests or would be observed in other CKD-prone populations (i.e., Sri Lankan/Indian sugarcane harvesters). In addition, it is unknown if any of the workers included in this study later developed signs of renal dysfunction, it is possible that observed trends might be more closely associated with long-term kidney health issues rather than the “snapshot” eGFR values used to assign groups in the current study. The use of creatinine to normalize for sample concentration also may obscure some group variation. Such factors could explain why elemental abundance and metabolic trends were consistent over the harvest but varied minimally across KFD/non-KFD groups. Another limitation is the use of untargeted liquid chromatography-mass spectrometry, which is valuable for initial exploration and trend identification, and should ideally be followed-up with more targeted approaches to confirm suspected metabolic and pathway changes. The use of urine as a biomatrix also limits heavy metal analysis, particularly given the discussed company water interventions. To properly evaluate chronic metal exposure, a blood test in addition to urine analysis would be ideal. Lastly, it is important to recognize that the experimental approach of this study is unable to determine directionality of associations. Changes to renal function, such as altered glomerular filtration rate or compromised proximal convoluted tubule uptake, could greatly impact elemental and metabolic expression. Therefore, though the findings of this study provide a promising start, future research is needed to further elucidate the role of perturbed lipid or amino acid msilica,ism, silica, and pesticides in CKD pathogenesis.
Disclosure
All the authors declared no competing interests.
Acknowledgments
The authors wish to thank the University of Colorado School of Pharmacy Mass Spectrometry Facility for their contributions to this manuscript. We wish to thank all of our collaborators at Grupo Pantaleon including Claudia Asensio, Alex Cruz, and Daniel Pilloni for their help in the field. We especially thank the workers who volunteered to participate in this research. This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK125351 and the National Institute of Environmental Health Sciences (NIEHS) grants T32 ES029074 and R21 ES028826. Grupo Pantaleon provided partial financial support for the research under a Memorandum of Understanding and contract with the University of Colorado, Anschutz Medical Campus and has provided on-site support for our field research team in the form of local office and lab space, transportation to field sites, and local lodging in Guatemala.
Author Contributions
ADS and KLR contributed to project conception, experimental design, data acquisition, and data analysis and interpretation. SB, JB-D, LK, and LSN contributed to sample collection, experimental design, data acquisition, and data analysis. AS contributed to data analysis. CAR-J and RJJ contributed to project conception and data analysis. JMB contributed to project conception, experimental design, and data analysis and interpretation. All authors were involved in drafting, revision, and final approval of the publishable version.
Footnotes
Figure S1. Specific compound hits from pathway analysis expressed as a fold change heat map across groups (PNG).
Table S1. Complete raw inductively coupled plasma mass spectrometry elemental analysis table (Excel).
Table S2. Complete raw metabolomic results table (Excel).
Table S3. Significantly impacted pathways based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) with P-values from pathway enrichment analysis and pathway impact values from pathway topology analysis (Excel).
Table S4. Complete raw pesticide metabolomic results table (Excel).
Supplementary Material
Figure S1. Specific compound hits from pathway analysis expressed as a fold change heat map across groups (PNG).
Table S1. Complete raw inductively coupled plasma mass spectrometry elemental analysis table (Excel).
Table S2. Complete raw metabolomic results table (Excel).
Table S3. Significantly impacted pathways based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) with P-values from pathway enrichment analysis and pathway impact values from pathway topology analysis (Excel).
Table S4. Complete raw pesticide metabolomic results table (Excel).
References
- 1.Food and Administration Organization of the United Nations FAOSTAT. http://www.fao.org/faostat/en/#data/QC Accessed February 21, 2024.
- 2.Leite M.R., Zanetta D.M.T., Trevisan I.B., Burdmann Ede A., Santos Ude P. Sugarcane cutting work, risks, and health effects: a literature review. Rev Saúde Publ. 2018;52:80. doi: 10.11606/S1518-8787.2018052000138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Laws R.L., Brooks D.R., Amador J.J., et al. Biomarkers of kidney injury among Nicaraguan sugarcane workers. Am J Kidney Dis Off J Natl Kidney Found. 2016;67:209–217. doi: 10.1053/j.ajkd.2015.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Le Blond J.S., Woskie S., Horwell C.J., Williamson B.J. Particulate matter produced during commercial sugarcane harvesting and processing: a respiratory health hazard? Atmos Environ. 2017;149:34–46. doi: 10.1016/j.atmosenv.2016.11.012. [DOI] [Google Scholar]
- 5.Johnson R.J., Wesseling C., Newman L.S. Chronic kidney disease of unknown cause in agricultural communities. N Engl J Med. 2019;380:1843–1852. doi: 10.1056/NEJMra1813869. [DOI] [PubMed] [Google Scholar]
- 6.Sasai F., Roncal-Jimenez C., Rogers K., et al. Climate change and nephrology. Nephrol Dial Transplant. 2023;38:41–48. doi: 10.1093/ndt/gfab258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chang C.-J., Yang H.-Y. Chronic kidney disease among agricultural workers in Taiwan: a nationwide population-based study. Kidney Int Rep. 2023;8:2677–2689. doi: 10.1016/j.ekir.2023.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Broe M.E.D., Vervaet B.A. Is an environmental nephrotoxin the primary cause of CKDu (Mesoamerican nephropathy)? PRO. Kidney360. 2020:591–595. doi: 10.34067/KID.0003172020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pearce N. Is CKDu an occupational or an environmental disease? Environ Epidemiol. 2019;3:306. [Google Scholar]
- 10.Floris M., Lepori N., Angioi A., et al. Chronic kidney disease of undetermined etiology around the world. Kidney Blood Press Res. 2021;46:142–151. doi: 10.1159/000513014. [DOI] [PubMed] [Google Scholar]
- 11.Ranasinghe A.V., Kumara G.W.G.P., Karunarathna R.H., et al. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients. BMC Nephrol. 2019;20:338. doi: 10.1186/s12882-019-1501-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Fischer R.S.B., Mandayam S., Chavarria D., et al. Clinical evidence of acute Mesoamerican nephropathy. Am J Trop Med Hyg. 2017;97:1247–1256. doi: 10.4269/ajtmh.17-0260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Selvarajah M., Weeratunga P., Sivayoganthan S., Rathnatunga N., Rajapakse S. Clinicopathological correlates of chronic kidney disease of unknown etiology in Sri Lanka. Indian J Nephrol. 2016;26:357–363. doi: 10.4103/0971-4065.167280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wimalawansa S.J. Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries. Heliyon. 2019;5 doi: 10.1016/j.heliyon.2019.e02309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Butler-Dawson J., Krisher L., Asensio C., et al. Risk factors for declines in kidney function in sugarcane workers in Guatemala. J Occup Environ Med. 2018;60:548–558. doi: 10.1097/JOM.0000000000001284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sorensen C.J., Butler-Dawson J., Dally M., et al. Risk factors and mechanisms underlying cross-shift decline in kidney function in Guatemalan sugarcane workers. J Occup Environ Med. 2019;61:239–250. doi: 10.1097/JOM.0000000000001529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Glaser J., Hansson E., Weiss I., et al. Preventing kidney injury among sugarcane workers: promising evidence from enhanced workplace interventions. Occup Environ Med. 2020;77:527–534. doi: 10.1136/oemed-2020-106406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zúñiga-Venegas L.A., Hyland C., Muñoz-Quezada M.T., et al. Z úñiga-V L. Health Effects of Pesticide Exposure in Latin American and the Caribbean Populations: a Scoping Review. Environ Health Perspect. 2022;130 doi: 10.1289/EHP9934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rajapaksha H., Pandithavidana D.R., Dahanayake J.N. Demystifying chronic kidney disease of unknown etiology (CKDu): computational interaction analysis of pesticides and metabolites with vital renal enzymes. Biomolecules. 2021;11:261. doi: 10.3390/biom11020261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Alvand S., Alatab S., Dalvand S., et al. Association of indoor use of pesticides with CKD of unknown origin. PLoS One. 2023;18 doi: 10.1371/journal.pone.0277151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Valcke M., Levasseur M.-E., Soares da Silva A., Wesseling C. Pesticide exposures and chronic kidney disease of unknown etiology: an epidemiologic review. Environ Health Glob Access Sci Source. 2017;16:49. doi: 10.1186/s12940-017-0254-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Fischer R.S.B., Unrine J.M., Vangala C., Sanderson W.T., Mandayam S., Murray K.O. Evidence of nickel and other trace elements and their relationship to clinical findings in acute Mesoamerican Nephropathy: a case-control analysis. PLoS One. 2020;15 doi: 10.1371/journal.pone.0240988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Anupama Y.J., Kiran S.K., Hegde S.N. Heavy metals and pesticides in chronic kidney disease - results from a matched case-control study from a rural population in Shivamogga District in South India. Indian J Nephrol. 2019;29:402–409. doi: 10.4103/ijn.IJN_325_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kulathunga M.R.D.L., Ayanka Wijayawardena M.A., Naidu R., Wijeratne A.W. Chronic kidney disease of unknown aetiology in Sri Lanka and the exposure to environmental chemicals: a review of literature. Environ Geochem Health. 2019;41:2329–2338. doi: 10.1007/s10653-019-00264-z. [DOI] [PubMed] [Google Scholar]
- 25.Rogers KL, Roncal-Jimenez CA, Leiva R, et al. Silica Nanoparticles and Mesoamerican Nephropathy: a case series. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2023.06.010 [DOI] [PubMed]
- 26.Stem A.D., Rogers K.L., Roede J.R., Roncal-Jimenez C.A., Johnson R.J., Brown J.M. Sugarcane ash and sugarcane ash-derived silica nanoparticles alter cellular metabolism in human proximal tubular kidney cells. Environ Pollut. 2023;332 doi: 10.1016/j.envpol.2023.121951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Paidi G., Iroshani Jayarathna A.I., Salibindla D.B.A.M.R., et al. Chronic kidney disease of unknown origin: a mysterious epidemic. Cureus. 2022;13 doi: 10.7759/cureus.17132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Raines N.H., Leone D.A., O’Callaghan-Gordo C., et al. Metabolic features of increased gut permeability, inflammation, and altered energy metabolism distinguish agricultural workers at risk for Mesoamerican nephropathy. Metabolites. 2023;13:325. doi: 10.3390/metabo13030325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jang H.-S., Noh M.R., Kim J., Padanilam B.J. Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases. Front Med (Lausanne) 2020;7:65. doi: 10.3389/fmed.2020.00065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Liu X., Du H., Sun Y., Shao L. Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention. Ren Fail. 2022;44:790–805. doi: 10.1080/0886022X.2022.2072743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Butler-Dawson J., Barnoya J., Brindley S., et al. Cross-sectional study examining the accuracy of self-reported smoking status as compared to urinary cotinine levels among workers at risk for chronic kidney disease of unknown origin in Guatemala. BMJ Open. 2021;11 doi: 10.1136/bmjopen-2021-050374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Butler-Dawson J., Krisher L., Yoder H., et al. Evaluation of heat stress and cumulative incidence of acute kidney injury in sugarcane workers in Guatemala. Int Arch Occup Environ Health. 2019;92:977–990. doi: 10.1007/s00420-019-01426-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Inker L.A., Eneanya N.D., Coresh J., et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737–1749. doi: 10.1056/NEJMoa2102953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Reisdorph N.A., Hendricks A.E., Tang M., et al. Nutrimetabolomics reveals food-specific compounds in urine of adults consuming a DASH-style diet. Sci Rep. 2020;10:1157. doi: 10.1038/s41598-020-57979-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Uffelman C.N., Doenges K.A., Armstrong M.L., et al. Metabolomics profiling of white button, crimini, portabella, Lion’s mane, maitake, oyster, and shiitake mushrooms using untargeted metabolomics and targeted amino acid analysis. Foods Basel Switz. 2023;12:2985. doi: 10.3390/foods12162985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wishart D.S., Feunang Y.D., Marcu A., et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46:D608–D617. doi: 10.1093/nar/gkx1089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.O’Donnell V.B., Dennis E.A., Wakelam M.J.O., Subramaniam S. LIPID MAPS: serving the next generation of lipid researchers with tools, resources, data, and training. Sci Signal. 2019;12 doi: 10.1126/scisignal.aaw2964. [DOI] [PubMed] [Google Scholar]
- 38.Smith C.A., O’Maille G., Want E.J., et al. Metlin: a metabolite mass spectral database. Ther Drug Monit. 2005;27:747–751. doi: 10.1097/01.ftd.0000179845.53213.39. [DOI] [PubMed] [Google Scholar]
- 39.Kanehisa M., Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30. doi: 10.1093/nar/28.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sunderman F.W. Biological monitoring of nickel in humans. Scand J Work. Environ Health. 1993;19(suppl 1):34–38. [PubMed] [Google Scholar]
- 41.U.S. Department of Labor Occupational safety and health administration. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1027
- 42.Toxicological profile for arsenic. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/11481
- 43.Toxicological profile for lead. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/95222
- 44.Jayasumana C., Orantes C., Herrera R., et al. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrol Dial Transplant. 2017;32:234–241. doi: 10.1093/ndt/gfw346. [DOI] [PubMed] [Google Scholar]
- 45.Nanayakkara S., Senevirathna S.T., Abeysekera T., et al. An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka. J Occup Health. 2014;56:28–38. doi: 10.1539/joh.13-0172-oa. [DOI] [PubMed] [Google Scholar]
- 46.Nayak S., Rehman T., Patel K., et al. Factors associated with chronic kidney disease of unknown etiology (CKDu): a systematic review. Healthcare. 2023;11:551. doi: 10.3390/healthcare11040551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zheng L., Kuo C.C., Fadrowski J., Agnew J., Weaver V.M., Navas-Acien A. Arsenic and chronic kidney disease: a systematic review. Curr Environ Health Rep. 2014;1:192–207. doi: 10.1007/s40572-014-0024-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Nyachoti S., Godebo T.R., Okwori O.F., Jeuland M.A., Manthrithilake H. Dietary exposures to metals in relation to chronic kidney disease of unknown cause (CKDu) in Sri Lanka. Expo Health. 2022;14:63–73. doi: 10.1007/s12403-021-00418-4. [DOI] [Google Scholar]
- 49.Rango T., Jeuland M., Manthrithilake H., McCornick P. Nephrotoxic contaminants in drinking water and urine, and chronic kidney disease in rural Sri Lanka. Sci Total Environ. 2015;518-519:574–585. doi: 10.1016/j.scitotenv.2015.02.097. [DOI] [PubMed] [Google Scholar]
- 50.Moody E.C., Coca S.G., Sanders A.P. Toxic metals and chronic kidney disease: a systematic review of recent literature. Curr Environ Health Rep. 2018;5:453–463. doi: 10.1007/s40572-018-0212-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kwon J.Y., Lee S., Surenbaatar U., et al. Association between levels of exposure to heavy metals and renal function indicators of residents in environmentally vulnerable areas. Sci Rep. 2023;13:2856. doi: 10.1038/s41598-022-27292-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Mascarenhas S., Mutnuri S., Ganguly A. Deleterious role of trace elements - Silica and lead in the development of chronic kidney disease. Chemosphere. 2017;177:239–249. doi: 10.1016/j.chemosphere.2017.02.155. [DOI] [PubMed] [Google Scholar]
- 53.Chen L., Liu J., Zhang Y., et al. The toxicity of silica nanoparticles to the immune system. Nanomedicine (Lond) 2018;13:1939–1962. doi: 10.2217/nnm-2018-0076. [DOI] [PubMed] [Google Scholar]
- 54.Chou C.C., Chen W., Hung Y., Mou C.Y. Molecular elucidation of biological response to mesoporous silica nanoparticles in vitro and in vivo. ACS Appl Mater Interfaces. 2017;9:22235–22251. doi: 10.1021/acsami.7b05359. [DOI] [PubMed] [Google Scholar]
- 55.Schütz I., Lopez-Hernandez T., Gao Q., et al. Lysosomal dysfunction caused by cellular accumulation of silica nanoparticles. J Biol Chem. 2016;291:14170–14184. doi: 10.1074/jbc.M115.710947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hornung V., Bauernfeind F., Halle A., et al. Silica crystals and aluminum salts mediate NALP-3 inflammasome activation via phagosomal destabilization. Nat Immunol. 2008;9:847–856. doi: 10.1038/ni.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Sasai F., Rogers K.L., Orlicky D.J., et al. Inhaled silica nanoparticles cause chronic kidney disease in rats. Am J Physiol Ren Physiol. 2022;323:F48–F58. doi: 10.1152/ajprenal.00021.2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Boudard D., Aureli F., Laurent B., et al. Chronic oral exposure to synthetic amorphous silica (NM-200) results in renal and liver lesions in mice. Kidney Int Rep. 2019;4:1463–1471. doi: 10.1016/j.ekir.2019.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Rogers K.L., Roncal-Jimenez C.A., Leiva R., et al. Silica nanoparticles and Mesoamerican nephropathy: a case series. Am J Kidney Dis. 2023 doi: 10.1053/j.ajkd.2023.06.010. [DOI] [PubMed] [Google Scholar]
- 60.Prasad N., Bhadauria D. Renal phosphate handling: physiology. Indian J Endocrinol Metab. 2013;17:620–627. doi: 10.4103/2230-8210.113752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Murer H., Hernando N., Forster I., Biber J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev. 2000;80:1373–1409. doi: 10.1152/physrev.2000.80.4.1373. [DOI] [PubMed] [Google Scholar]
- 62.Cupisti A., Gallieni M. Urinary phosphorus excretion: not what we have believed it to be? Clin J Am Soc Nephrol CJASN. 2018;13:973–974. doi: 10.2215/CJN.06260518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Vervloet M.G., Sezer S., Massy Z.A., et al. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13:27–38. doi: 10.1038/nrneph.2016.164. [DOI] [PubMed] [Google Scholar]
- 64.Suki W.N., Moore L.W. Phosphorus regulation in chronic kidney disease. Methodist DeBakey Cardiovasc J. 2016;12(suppl):6–9. doi: 10.14797/mdcj-12-4s1-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.González-Parra E., Gracia-Iguacel C., Egido J., Ortiz A. Phosphorus and nutrition in chronic kidney disease. Int J Nephrol. 2012;2012 doi: 10.1155/2012/597605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Kawasaki T., Maeda Y., Matsuki H., Matsumoto Y., Akazawa M., Kuyama T. Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol. 2015;16:116. doi: 10.1186/s12882-015-0118-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Lebov J.F., Engel L.S., Richardson D., Hogan S.L., Hoppin J.A., Sandler D.P. Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health Study. Occup Environ Med. 2016;73:3–12. doi: 10.1136/oemed-2014-102615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Siddarth M., Datta S.K., Mustafa M., et al. Increased level of organochlorine pesticides in chronic kidney disease patients of unknown etiology: role of GSTM1/GSTT1 polymorphism. Chemosphere. 2014;96:174–179. doi: 10.1016/j.chemosphere.2013.10.029. [DOI] [PubMed] [Google Scholar]
- 69.Stalin P., Purty A.J., Abraham G. Distribution and determinants of chronic kidney disease of unknown etiology: A brief overview. Indian J Nephrol. 2020;30:241–244. doi: 10.4103/ijn.IJN_313_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Kaur B., Khera A., Sandhir R. Attenuation of cellular antioxidant defense mechanisms in kidney of rats intoxicated with carbofuran. J Biochem Mol Toxicol. 2012;26:393–398. doi: 10.1002/jbt.21433. [DOI] [PubMed] [Google Scholar]
- 71.Kim S., Gil H.W., Yang J.O., Lee E.Y., Hong S.Y. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant. 2009;24:1226–1232. doi: 10.1093/ndt/gfn615. [DOI] [PubMed] [Google Scholar]
- 72.Soloukides A., Moutzouris D.A., Kassimatis T., Metaxatos G., Hadjiconstantinou V. A fatal case of paraquat poisoning following minimal dermal exposure. Ren Fail. 2007;29:375–377. doi: 10.1080/08860220601184134. [DOI] [PubMed] [Google Scholar]
- 73.Wesseling C., Hogstedt C., Picado A., Johansson L. Unintentional fatal paraquat poisonings among agricultural workers in Costa Rica: report of 15 cases. Am J Ind Med. 1997;32:433–441. doi: 10.1002/(sici)1097-0274(199711)32:5<433::aid-ajim1>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- 74.Yu G., Wang J., Jian T., et al. Case series: Diquat poisoning with acute kidney failure, myocardial damage, and rhabdomyolysis. Case series. Front Public Health. 2022;10 doi: 10.3389/fpubh.2022.991587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Holliday M.W., Majeti R.N., Sheikh-Hamad D. Chronic interstitial nephritis in agricultural communities: observational and mechanistic evidence supporting the role of nephrotoxic agrochemicals. Clin J Am Soc Nephrol. 2024;19:538–545. doi: 10.2215/CJN.0000000000000312. doi: 10.2215/CJN.0000000000000312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Bhargava P., Schnellmann R.G. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13:629–646. doi: 10.1038/nrneph.2017.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Covarrubias A.J., Perrone R., Grozio A., Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22:119–141. doi: 10.1038/s41580-020-00313-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Bignon Y., Rinaldi A., Nadour Z., et al. Cell stress response impairs de novo NAD+ biosynthesis in the kidney. JCI Insight. 2022;7 doi: 10.1172/jci.insight.153019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Katsyuba E., Mottis A., Zietak M., et al. De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature. 2018;563:354–359. doi: 10.1038/s41586-018-0645-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Poyan Mehr A., Tran M.T., Ralto K.M., et al. De novo NAD+ biosynthetic impairment in acute kidney injury in humans. Nat Med. 2018;24:1351–1359. doi: 10.1038/s41591-018-0138-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Kang H.M., Ahn S.H., Choi P., et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21:37–46. doi: 10.1038/nm.3762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Gao Z., Chen X. Fatty acid β-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities. Front Pharmacol. 2022;13 doi: 10.3389/fphar.2022.805281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Chen H., Chen L., Liu D., et al. Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J Proteome Res. 2017;16:1566–1578. doi: 10.1021/acs.jproteome.6b00956. [DOI] [PubMed] [Google Scholar]
- 84.Gai Z., Wang T., Visentin M., Kullak-Ublick G.A., Fu X., Wang Z. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11:722. doi: 10.3390/nu11040722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Szeto H.H., Liu S., Soong Y., Alam N., Prusky G.T., Seshan S.V. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int. 2016;90:997–1011. doi: 10.1016/j.kint.2016.06.013. [DOI] [PubMed] [Google Scholar]
- 86.Mister M., Noris M., Szymczuk J., et al. Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int. 2002;61:1064–1078. doi: 10.1046/j.1523-1755.2002.00212.x. [DOI] [PubMed] [Google Scholar]
- 87.Origlia N., Migliori M., Panichi V., et al. Protective effect of l-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. Biomed Pharmacother. 2006;60:77–81. doi: 10.1016/j.biopha.2005.06.014. [DOI] [PubMed] [Google Scholar]
- 88.Lee H., Jang H.B., Yoo M.-G., Park S.I., Lee H.-J. Amino acid metabolites associated with chronic kidney disease: an eight-year follow-up Korean epidemiology study. Biomedicines. 2020;8:222. doi: 10.3390/biomedicines8070222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Davies R. The metabolomic quest for a biomarker in chronic kidney disease. Clin Kidney J. 2018;11:694–703. doi: 10.1093/ckj/sfy037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Zhang Z.-H., Wei F., Vaziri N.D., et al. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep. 2015;5 doi: 10.1038/srep14472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Silva R.E., Baldim J.L., Chagas-Paula D.A., et al. Predictive metabolomic signatures of end-stage renal disease: a multivariate analysis of population-based data. Biochimie. 2018;152:14–30. doi: 10.1016/j.biochi.2018.06.009. [DOI] [PubMed] [Google Scholar]
- 92.Chasapi S.A., Karagkouni E., Kalavrizioti D., et al. NMR-based metabolomics in differential diagnosis of chronic kidney disease (CKD) subtypes. Metabolites. 2022;12:490. doi: 10.3390/metabo12060490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Rhee E.P., Clish C.B., Wenger J., et al. Metabolomics of CKD progression: a case-control analysis in the chronic renal insufficiency cohort study. Am J Nephrol. 2016;43:366–374. doi: 10.1159/000446484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Mutter S., Valo E., Aittomäki V., et al. Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes. Diabetologia. 2022;65:140–149. doi: 10.1007/s00125-021-05584-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Shih Y.-L., Shih C.-C., Chen J.-Y. Elevated homocysteine level as an indicator for chronic kidney disease in community-dwelling middle-aged and elderly populations in Taiwan: a community-based cross-sectional study. Front Med (Lausanne) 2022;9 doi: 10.3389/fmed.2022.964101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Jankowski J., van der Giet M., Jankowski V., et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003;112:256–264. doi: 10.1172/JCI15524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Morita M., Yano S., Yamaguchi T., Yamauchi M., Sugimoto T. Phenylacetic acid stimulates reactive oxygen species generation and tumor necrosis factor-α secretion in vascular endothelial cells. Ther Apher Dial. 2011;15:147–150. doi: 10.1111/j.1744-9987.2010.00887.x. [DOI] [PubMed] [Google Scholar]
- 98.Schulz A.M., Terne C., Jankowski V., et al. Modulation of NADPH oxidase activity by known uraemic retention solutes. Eur J Clin Investig. 2014;44:802–811. doi: 10.1111/eci.12297. [DOI] [PubMed] [Google Scholar]
- 99.Kanchanasurakit S., Arsu A., Siriplabpla W., Duangjai A., Saokaew S. Acetaminophen use and risk of renal impairment: a systematic review and meta-analysis. Kidney Res Clin Pract. 2020;39:81–92. doi: 10.23876/j.krcp.19.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Miettinen T.P., Björklund M. NQO2 is a reactive oxygen species generating off-target for acetaminophen. Mol Pharm. 2014;11:4395–4404. doi: 10.1021/mp5004866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Schaub J.A., Venkatachalam M.A., Weinberg J.M. Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD. Kidney360. 2021;360:355–364. doi: 10.34067/KID.0004772020. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






